Tag: Daiichi Sankyo
-
Eliquis, Savaysa, And Xarelto: New Blood Thinner Drugs Feared By Many Doctors Because No Antidote Is Available When Needed
Some Recent Articles Point Out the Real Problems And Consequences Of Major Bleeding Events Involving Eliquis, Savaysa, And Xarelto (Posted by Tom Lamb at DrugInjuryWatch.com) As many of you know from direct-to-consumer…
-
A French Medical Study Provides More Support For Apparent Link Between Benicar With Chronic Severe Diarrhea And Substantial Weight Loss Side Effects
Researchers Found An Almost 10-Times Increased Risk Of Severe Intestinal Malabsorption Associated With Benicar After 2-Years Use Compared To Some Other Blood Pressure Medications (Posted by Tom Lamb at DrugInjuryWatch.com) We continue to hear about patients who…
-
Benicar Cardiovascular-Related Deaths: FDA Safety Review Which Started In June 2010 Is Still Ongoing In August 2013
When Will Daiichi Sankyo And FDA Report On Additional Studies And Analyses Of Clinical Studies About Cardiovascular Mortality Increased Risks Of Benicar (Posted by Tom Lamb at DrugInjuryWatch.com) In June 2010 the FDA issued…
-
Blood Pressure Drug Benicar Causes Serious Intestinal Side Effects Such As Chronic And Severe Diarrhea Months Or Years After Starting Drug
Olmesartan-associated Sprue-like Enteropathy FDA Warning Also Applies To Benicar HCT, Azor, And Tribenzor From Drug Company Daiichi Sankyo (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA has found clear evidence of an association between…
-
Blood Pressure Medication Benicar (Olmesartan) Might Be Unsafe For Some Patients
Two Clinical Studies Find Patients With Type 2 Diabetes Taking Benicar Had Higher Rate Of Death From A Cardiovascular Cause (Posted by Tom Lamb at DrugInjuryWatch.com) On June 11, 2010 the FDA announced that…